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ASSOCIATION OF ELECTRONIC PRESCRIPTION IN CONTROLLED SUBSTANCES
USED
ABSTRACT
Introduction: Controlled substances have been described as pharmaceuticals or illegal medicines
that act primarily on the central nervous system and could cause physical and mental
dependence, eventually leading to addiction. Prescription opioids were a significant contributor
to the opioid epidemic, accounting for more than 70,000 opioid-related overdose deaths,
including illicit and prescription opioids, between 2018 and 2019. The Electronic Prescriptions
for Controlled Substances (EPCS) initiative recently aimed to reduce rates of prescription opioid
addiction, abuse, diversion, and death.
The system for controlled substances had become more widely used as providers and
governments trying to combat the opioid problem. Because of its ability to prevent prescription
forgery and identify multiple prescribers of prescribing and dispensing, e-prescribing for
controlled substance (EPCS) had been believed to improve pain management and could play a
key role in addressing the growing public health crisis of controlled substance abuse and
overdose
Methodology: This research methodology involved a study of literature comprising several
literature reviews. Six electronic databases were employed in the search. Overall, sources were
thoroughly selected and referenced. The semi-structured interview was also carried with the
provider working with the EPCS system in the Hospital.
Results: The literature analysis considered disparate studies relevant to the association of
electronic prescription in controlled substances used. There was a mixed result; however,
following the investigation of the review, and expertise interview the results have shown that
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utilization of the EPCS had the potential to detect and prevent opioid diversion by eliminating
paper prescriptions and could improve healthcare quality, safety, and efficiency while also
lowering drug costs.
Discussion/Conclusion: Providers who have been prescribing controlled medications should
develop prescription methods that reduce or prevent adverse effects from avoiding misuse. With
the central coordination and clinical leadership, meaningful reductions in opioid overprescribing
are possible and sustainable without decreasing patient satisfaction.
Keywords: Electronic prescription-controlled substances, EPCS, prescription narcotics,
pharmacology opioid misused, Drug abuse, Illicit drugs, Opioid epidemics.
INTRODUCTION
Controlled substances have been described as a drug or other substance strictly regulated by the
government due to the risk of abuse or addiction. The regulation covers how the substance had
been manufactured, used, handled, stored, and disseminated. Opioids, stimulants, depressants,
hallucinogens, and anabolic steroids have been controlled substances (Aro, Hussain, & Bobrin,
2021). In 2019, overdoses involving opioids killed approximately 50,000 people, with synthetic
opioids accounting for nearly 73 percent of those deaths; Synthetic opioids, mainly illicitly made
fentanyl, are at the heart of the overdose pandemic. Overdoses involving psychostimulants like
methamphetamine are also on the rise, both with and without the use of synthetic opioids
(Scholl, Seth, Kariisa, Wilson, & Baldwin, 2018). Even though controlled substances account for
only 11% of all written, they were prescribed by 90%, making it critical to include them in eprescribing systems (Thomas et al., 2012). Electronic Prescribing for Controlled Substances
aimed to eliminate paper prescriptions by allowing clinical prescribers to write controlled drug
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prescriptions electronically, making them digital and trackable for both the prescriber and the
pharmacist and had been an essential part of any health information technology system, as well
as a requirement for 'meaningful use' (Blumenthal & Tavenner, 2010). However, one of the
single most difficult challenges for any prescriber was distinguishing between the legitimate
prescription of controlled substances versus the prescription potentially used for illegitimate
purposes (Preuss, Kalava, & King, 2021). The fact that different people have varying tolerance
levels and require different opioid doses to achieve adequate pain relief was perhaps the most
challenging aspect of caring for patients with pain (D'Aunno, Park, & Pollack, 2019).
To limit the likelihood of drug diversion and abuse, the DEA acknowledged the
importance of ensuring that the rules regulating electronic prescription (EPCS) did not
unintentionally enabled diversion and abuse (Abramson et al., 2012). The DEA's Interim Final
Rule (on EPCS went into effect in June 2010, allowing for e-prescribing and laying out the rules
for its use in the U.S (DEA., 2010). Providers, pharmacies, prescription system application
vendors, and pharmacy system vendors were all subject to the rules (Kannry, 2011). Providers,
pharmacies, prescription system application vendors, and pharmacy system vendors were all
subject to the regulations (Kannry, 2011).
The Electronic Prescriptions for Controlled Substances (EPCS) aimed to reduce
prescription opioid addiction, abuse, diversion, and death (Danovich et al., 2019). Additionally,
E-prescribing could improve healthcare quality, safety, and efficiency (Kaushal, Kern, Barrón,
Quaresimo, & Abramson, 2010). The potential benefits of EPCS enhanced patient management
and reduced prescription fraud associated with paper prescriptions, which account for a small but
significant proportion of opioid medications diverted for abuse (Fischer et al., 2010). EPCS was
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gaining popularity because of its ability to detect and prevent opioid diversion by removing
paper prescriptions and allowing cross-referencing PDMP databases (Gawande, 2017). Without
sacrificing convenience, EPCS provided accountability and security, and It's a potent weapon in
the fight against the nation's opioid problem (Kausha et al., 2010). While EPCS regulations could
improve patient care and provide practitioners with more data for quality improvement, they
might also offer new obstacles to practitioners, facilities, and vendors (Kaldy, 2016).
EPCS mandates were in place in 23 states and were passed in September 2021.
Furthermore, by 2022, all controlled drugs covered by Medicare Part D must be dispensed
through electronic prescribing (Imprivata., 2021). Many current state and local laws aimed at
better tracking controlled-substance prescriptions using e-prescribing technology, in conjunction
with prescription drug monitoring programs, have aided adoption (Everson, Cheng, Patrick, &
Dusetzina, 2020).
Therefore, this research aimed to analyze and assess the association between electronic
prescribing-controlled substances and their impact on opioid prescribing.

METHODOLOGY
The working hypothesis was that electronic prescribing of controlled substances has intended to
reduce opioid prescribing rates by reducing fraud and experienced more significant reductions in
opioid prescribing
This qualitative study's methodology combined literature research with a semi-structured
interview with the providers.
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The conceptual framework for this research followed the research framework and process utilized
by Yao, Chu, and Li (2010), Figure 1. The methodology used for this research study was a review
of academic literature, involving the following steps:
Step 1: Literature Identification and Collection
The electronic databases of Marshall University nursing allied health, Marshall University
Digital Scholar, ProQuest, PubMed research databases, Evidence-Based Medicine, JAMA, and
Cochrane were searched for the terms "Electronic Prescription Controlled substances" OR "EPCS"
OR "E narcotics prescription" OR "Prescription AND "Pharmacology opioid misused" OR
"OPIOIDS" OR "DRUG Abuse" "AND "The United States." Government websites, The Journals
of ONDC, CMS and Drug enforcement administration (DEA), ARHQ Evidence-based practice
center, and Imprivata were cited. Using the Preferred Reporting Items for Systematic Reviews and
Meta-Analysis and PRISMA method (Moher, Liberati, Tetzlaff, Altman, & The PRISMA Group
2009). The search established 122 relevant articles were identified, and articles were excluded
(N=94) if they did not meet inclusion criteria. Articles were included (N=28) if they explained the
effect of electronic prescribing-controlled substances that had reduced the fraud and misuse of
opioids. The 28 articles were thoroughly investigated and finally included in the data analysis, and
10 were used for the results, and 17 were used in the introduction.
Step 2: Formation of Inclusion Principles and Literature Analysis
A total of 32 Articles, written in English and published from 2010-2021, with relevant
information about the electronic prescribing of controlled substances that intended to reduce opioid
prescribing rates by reducing fraud and experienced more significant reductions in opioid
prescribing, were scrutinized and used in the data analysis and presentation of the project study.
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Also, the information found in the literature review was complemented by relevant details obtained
from a semi-structured interview with the physician who has had enough expertise with EPCS
used for the past five years in Geisinger medical center. The interview session was recorded on
co-investigator's phone with approval from the Institutional Review Boards (IRB). (See Appendix
A: Semi-Structured Interview Questions with an expert physician). The clinician was cited as an
expert EPCS management throughout the review of this study. The literature search was
performed by AS, J.O., and validated by A.C., who acted as second reader and counter-checked to
confirm that references met the inclusion criteria.
RESULTS
In a study done between January 2014 and March 2015, the number of pharmacies that were
equipped with (EPCS) increased slightly, from 78% (46,711 pharmacies) to 79% (47,971
pharmacies) across the country (Gabriel, Smith, Sow, Joseph, & Wilkins, 2016). The degree to
which a state was able to help its citizens varied tremendously. In March 2015, for example, state
pharmacy enablement ranged from 30% to 92%. The highest rate of EPCS pharmacy facilitation
was in Rhode Island (96%), and the lowest was in North Dakota (30%). Between January 2014
and March 2015, national EPCS enablement among prescribers increased by 3.7%, from 0.6% to
4.3%, with more enablement in the urban areas than rural areas (Gabriel et al., 2016).
Residents were the most common kind of provider who supplied opioid prescriptions at
discharge (79.1%), followed by advanced practice professionals (APP, 77.6%), and finally
attending physicians (71.6%) (Cao, Monteiro, & Wills, 2020). According to a web-based survey
done in Finland involving 269 GPs, GPs' job flexibility has been boosted by electronic health
records and e-prescribing (Kivekäs, Enlund, Borycki, & Saranto, 2016).
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Electronic prescription of controlled substances and fraud.
EPCS improved patient safety by reducing the risk of fraud and diversion observed with paper
opioid prescriptions. With up to 9% of opioid paper prescriptions suspected of being forged or
fraudulent, the widespread use of EPCS has substantially influenced opioid prescribing (Achar,
Sinha, & Norcross, 2021).
According to the DEA, EPCS reduced the following types of prescription diversion: stealing
prescription pads or printing them and writing non-legitimate paper prescriptions; altering a
legitimate prescription to obtain a higher dose or more dosage units (e.g., changing a "10" to a
"40"); phoning-in non-legitimate remedies late in the day when it is difficult for a pharmacy to
complete a confirmation call to the practitioner's office; and altering a prescription record at the
pharmacy to hide diversion from pharmacy stock (Achar et al., 2021).
Electronic prescribing of controlled substances and the opioid crisis.
In a case study done at Anne Arundel Medical Center from April 2016 to April 2018, about
44,000 clinical contacts were documented. From a beginning level of 34.4 MME per encounter
per month, the total health system MME per encounter fell by 1.0 MME per encounter per
month. The monthly MME per interaction was 58% lower after the post-intervention observation
than the 6-month baseline average. From a baseline level of 428 MME per prescription per
month, morphine milligram equivalents per opioid prescription declined by 8 MME per month.
The MME per prescription each month was 34% lower after the 16-month post-intervention
period than at the start (Meisenberg, Grover, Campbell, & Korpon, 2018). From a starting point
of 11.5%, the percentage of clinical contacts resulting in an opioid prescription was lowered by
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0.2% each month. The opioid prescription rate was 38% lower at the end of the 16-month postintervention period than at the start (Meisenberg et al., 2018).
A case study done at Yale New Haven Health System from February 2017 to August 2017
revealed that the median number of opioid pills prescribed per surgery reduced from about 30
pills per patient before the prescription default modification to about 20 pills per patient
following the change in the prescription default (Chiu et al., 2018). Prescriptions issued for 30
pills reduced from 39.7% (554 of 1397) before the EPCS to 12.9% (183 of 1420) after the EPCS,
while prescriptions written for 12 pills rose from 2.1% (29 of 1397) before EPCS to 24.6% (349
of 1420) after EPCS. The number of prescriptions written for 20 tablets increased significantly
from 12.2% (171 of 1397) before EPCS to 19.6% (278 of 1420) after EPCS. After acquiring
EPCS, the total opioid prescription reduced by 34.41 MME prescribed (Chiu et al., 2018).
In a study done at a dental facility in New York from December 1st, 2012, to February 28th,
2013, over three months before the required Prescription Drug Monitoring Programs (PDMP),
and from December 1st, 2013, and February 28th, 2014, after PDMP implementation, Table 1
shows the frequency and quantity (numbers of tablets) of opioid and non-opioid analgesics
prescribed for dental emergency patients. The most prescribed opioid analgesics were
hydrocodone, codeine, and oxycodone (Rasubala, Pernapati, Velasquez, Burk, & Ren, 2015).
Ibuprofen and acetaminophen were the most prescribed non-opioid analgesics. Following the
mandated PDMP's introduction, there was a general trend toward fewer opioid prescriptions and
more non-opioid analgesic prescriptions (Table 1). By the end of the trial, the total number of
opioid analgesics prescribed over three months dropped from 5096 to 1120 pills, a 78% decrease
in absolute numbers (Rasubala et al., 2015).
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States implementing both mandatory PDMP used, and pain clinic laws were significantly
associated with reducing the combined drug overdose death rate of −1.1 per 100,000 residents
(Dowell, Zhang, Noonan, & Hockenberry, 2016). Combining mandatory provider reviews of
state-run prescription drug monitoring program data with pain clinic regulations reduced opioid
prescription volumes by 8% and prescription opioid overdose death rates by 12% (Brandeau,
Pitt, & Humphreys, 2018).
Cost of implementation of electronic prescribing for controlled substances.
Scalise and colleagues found that the cost of implementing a simple e-prescribing platform
ranges from $1,500 to $4,000 per practitioner in a 2007 study. An advanced system with alarms,
reminders, and system integration costs $29,000 per physician the first year and $4,000 per
physician each year after that (Hahn & Lovett, 2014).
DISCUSSION
EPCS had been an essential tool in healthcare facilities. It facilitated the monitoring of
prescribed controlled substances, curbing prescription errors that might occur. This would have
helped provide a better quality of care to patients. EPCS provides a complete record of controlled
substance prescription; both physicians and patients could be monitored through it. These had
been particularly important for public health, and law enforcement initiatives like the DEA
addressing misuse and diversion of opioid medications as detecting and curbing fraud associated
with controlled substances might have become easier.
The clinical response to the opioid crisis were specific obligation for health systems and
their physician leaders. They employed or contract with many clinicians both in hospitals and in
the community, they were frequently the conveners of organized medical staff quality
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improvement, they had been having a mission to improved and protect the public's health, and
existing channels of communication to educate and inform the public and patients about opioid
risks and alternatives.
Although slow, there is progress in acquiring EPCS as utilization and sustainability of the
system, which had been very expensive for most hospitals since they do not receive financial
support from the HITECH act of 2009, whose primary focus is EHR.
Barriers to implementation of EPCS.
The main barrier to the implementation of EPCS had been the financial commitment required.
Hospitals might have to invest their own money in an e-prescribing system, which was very
expensive. HITECH Act of 2009 only covers EHR deployment and had allocated about 22
billion EHR used.
LIMITATION
This literature review had several limitations, resulting from the search approach used. Articles
used for the research were restricted to relevant Electronic Prescription Controlled substances.
While EPCS shows to be promising in controlling the opioid crisis, these findings do not apply
to all hospitals and clinical settings; they have policy implications and cost factors. The
possibility of inadvertently omitting helpful information from the review could have been high
due to the method employed. A case study on implementing the EPCS method used in hospitals
was limited in search. Finally, there was the likelihood of author, publisher, and affiliation bias
in the material used for the literature review.
PRACTICAL IMPLICATION
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The practical suggestion resulting from this literature and case study must be evaluated in the
future analysis includes consideration of outcome for the control of opioids epidemic nation
widely after implementing Electronic Prescription Controlled substances effect achieving scale.
Adopting EPCS widely might improve overall safety efficacy, quality, and control of the opioid
crisis.
CONCLUSION
Although EPCS has decreased the overall prescription rate of controlled substances, it is unclear
whether this has helped reduce the opioid crisis. With central coordination and clinical
leadership, meaningful reductions in opioid overprescribing are possible and sustainable without
decreasing patient satisfaction.
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Figure 1. Conceptual Framework created by investigators using SmartDraw and adapted from that
of Yao, et al (2010) (Yao et al., 2010; SmartDraw, 2019).
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Figure 2: Overview of Literature Evaluation adapted from Moher, Liberati, Tetzlaff, Altman,
The PRISMA Group (2009) For more information, visit www.prisma-statement.org.

APPENDIX A.
SEMI_STRUCTURED INTERVIEW QUESTIONNAIRE: ASSOCIATION OF
ELECTRONIC PRESCRIBING WITH CONTROLLED SUBSTANCE USE.
1. Have you ever used e-prescribing when prescribing controlled substances?
2. How long have you used e-prescribing for controlled substances?
3. In the last 30 days, how many times have you prescribed controlled substances?
4. Would you say that the frequency of prescribing controlled substances has increased or
decreased since the introduction of e-prescribing?
5. What is the barrier that you face in prescribing controlled substances using e-prescribing?
6. Do you think e-prescribing of controlled substances has helped reduce the opioid
pandemic?
7. Has e-prescribing led to benefit in controlling the opioid pandemic?
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8. Do you think e-prescribing has helped decrease fraud associated with controlled
substances in hospitals?
9. How has e-prescribing helped decrease fraud in hospitals?
10. Do you think e-prescribing is a sustainable trend in attempts to decrease the use of
controlled substances?

TABLE 1.
Frequency and quantity (numbers of pills) of pain medication prescriptions for dental emergency
patients before and after implementation of the mandatory prescription drug monitoring program
(PDMP) (Rasubala et al., 2015).
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